Form 4 · Filed May 20, 2026, 08:12 PM UTC
CRVS/Corvus Pharmaceuticals, Inc.
MILLER RICHARD A MD — President and CEO
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 18, 2026 | P | buy | 5,000 | $12 | $60,250 | 1,193,103 |
| May 18, 2026 | P | buy | 1,932 | $12 | $23,203 | 1,195,035 |
Source: SEC EDGAR raw filing ↗ · Accession 0001610717-26-000160